In May 2014 dorsaVi welcomed Jerome Whelan and John Kowalczyk to its Executive Management Team as Chief Financial Officer and President of dorsaVi US.
Mr Kowalczyk is a seasoned executive in the United States medical devices market having spent 19 years with Medtronic, Inc. a global provider of medical technologies and devices. Mr Kowalczyk spent the last eight years as Vice President of Sales across Medtronic’s Neuromodulation business, the third-largest of the Company’s business units.
During his time at Medtronic Mr Kowalczyk was involved in successfully bringing new technologies to market and expanding existing product penetration.
Mr Whelan is a highly regarded, globally-experienced finance executive whose areas of expertise include financial operational management, corporate accounting, financial analysis, forecasting, change management, process redesign and new systems integration.
Prior to joining dorsaVi Mr Whelan was Australian Chief Financial Officer of SapientNitro, the marketing, commerce and technology division of Sapient Corp (NASDAQ: SAPE). Before this, Mr Whelan spent five years in New York working in Finance Directors roles for two of the world’s largest brand consulting and media buying agencies, FutureBrand and OMD.
“I am delighted to welcome Mr Whelan and Mr Kowalczyk to dorsaVi’s Executive Management Team and I look forward to continuing to work with them both as we enter the new financial year,” said dorsaVi CEO Andrew Ronchi.
“Mr Whelan’s mix of international business and operating experience coupled with Mr Kowalczyk’s wealth of knowledge and experience in the US healthcare market will help speed up the establishment of dorsaVi’s global operations.”
Earlier in the year with the expansion of dorsaVi in Europe the appointment of Chief Operating Officer Europe, Zoë Whyatt, was made. Zoë has strong experience in driving high growth technology companies globally and implementing processes to ensure rapid growth is managed efficiently within the business.